Finanzwire Finanzwire
Basculer en Français
11219 Companies
248788 Keywords
176578 Articles
134626 Press releases
Headlines Articles Press releases CYPRUMED GmbH Remove
  1. Home
  2. Companies
  3. CYPRUMED GmbH
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/29/2026 at 10:05, 24 days 1 hour ago

    Cyprumed's Oral Delivery Technology Enters Clinical Phase with MSD Trial

    Clinical Development Phase I Trial Cyprumed Oral Delivery Technology MSD Collaboration
  • PRESS RELEASE

    published on 09/29/2026 at 10:00, 24 days 1 hour ago

    Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial

    Cyprumed's oral delivery technology advances to clinical stage as MSD initiates Phase I trial, marking a significant milestone in drug development
    Phase I Trial Clinical Stage Cyprumed MSD Oral Delivery Technology
    Logo of CYPRUMED GmbH
  • BRIEF

    published on 04/15/2025 at 09:05, 1 year 6 months ago

    Cyprumed Partners with MSD on Oral Peptide Therapeutics

    Drug Delivery Technology License Agreement Cyprumed MSD Partnership Oral Peptide Therapeutics
  • PRESS RELEASE

    published on 04/15/2025 at 09:00, 1 year 6 months ago

    Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

    Cyprumed and MSD sign a Non-Exclusive License and Option Agreement for the Development of Oral Peptide Therapeutics, potentially unlocking new opportunities in peptide therapeutics
    Drug Delivery Technology License Agreement Cyprumed Oral Peptide Therapeutics MSD
    Logo of CYPRUMED GmbH
Accesswire
  • Published on 10/23/2026 at 02:20, 8 hours 54 minutes ago

    Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering

  • Published on 10/22/2026 at 23:30, 11 hours 44 minutes ago

    Cypher Announces Subscription Receipt Offering

  • Published on 10/22/2026 at 22:30, 12 hours 44 minutes ago

    Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update

  • Published on 10/22/2026 at 16:00, 19 hours 14 minutes ago

    Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million

  • Published on 10/22/2026 at 14:30, 20 hours 44 minutes ago

    Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components

View all ACCESSWIRE
EQS Group
  • Published on 10/23/2026 at 11:00, 13 minutes ago

    Annual General Meeting Approves Contribution: Innok Robotics on Course for the Public Capital Market

  • Published on 10/23/2026 at 10:58, 15 minutes ago

    How can digitalization improve healthcare?

  • Published on 10/23/2026 at 10:18, 55 minutes ago

    Schirp Schjmidt-Morsbach Rechtsanwälte PartG: Investor Lawsuits in the Wirecard Case: Federal Court of Justice Dismisses EY from Model Proceedings The lead plaintiff’s attorneys welcome the decision

  • Published on 10/23/2026 at 10:05, 1 hour 8 minutes ago

    SINEXCEL Achieves IEC 62443-4-1 Certification for Cybersecurity Compliance

  • Published on 10/23/2026 at 09:00, 2 hours 13 minutes ago

    Municipality Finance issues a USD 135 million tap under its MTN programme

View all EQS
Les Echos
  • Published on 10/23/2026 at 07:00, 4 hours 14 minutes ago

    Safran reports third quarter 2026 revenue

  • Published on 10/22/2026 at 18:00, 17 hours 14 minutes ago

    THERMADOR GROUPE : Completion of the share buy-back programme launched in August

  • Published on 10/22/2026 at 18:00, 17 hours 14 minutes ago

    bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics

  • Published on 10/22/2026 at 18:00, 17 hours 14 minutes ago

    H1 2026: marked improvement in operating results

  • Published on 10/22/2026 at 17:47, 17 hours 26 minutes ago

    Aéroports de Paris SA - 2026 9-month revenue

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy